Correction to: Efficacy of Radiofrequency Ablation in Patients with Metastatic Liver Tumors from Breast Carcinoma
Authors
Abstract:
In the article published in Volume 27, issue 158, 2017, the Results section in English Abstract have been published incorrectly. The correct Results is given below: Results: The most frequent sizes of mass were 2-4 cm (n=33, 54%) and 4-5 cm (n=23, 38%). Among the patients, 35 (67.3%) had one tumor before, in 11.5% renew tumor happened, and 65.4% had one tumor after treatment. Liver tumors were controlled in 76.9% in case group which was statistically higher than that in control group (P< 0.0001).
similar resources
Radiofrequency Ablation of Primary or Metastatic Liver Tumors
©2017 Blue Cross and Blue Shield of Louisiana An independent licensee of the Blue Cross and Blue Shield Association No part of this publication may be reproduced, stored in a retrieval system, or transmitted, in any form or by any means, electronic, mechanical, photocopying, or otherwise, without permission from Blue Cross and Blue Shield of Louisiana. Page 1 of 20 Applies to all products admin...
full textRadiofrequency ablation of primary and metastatic liver tumors.
Worldwide, hepatocellular carcinoma (HCC) is one of the most common and deadly solid cancers. At least one million new patients are diagnosed annually with this cancer. Incidence in non-Western countries is related to infections of hepatitis B virus and dietary ingestion of aflatoxins, whereas in Western countries alcohol-related cirrhosis and chronic hepatitis C virus infection are leading cau...
full textTherapeutic efficacy comparison of radiofrequency ablation in hepatocellular carcinoma and metastatic liver cancer
The aim of this study was to evaluate the effect of radiofrequency ablation (RFA) on malignant hepatic tumors and compare its therapeutic efficacy in hepatocellular carcinoma (HCC) and metastatic liver cancer (MLC). A total of 56 patients with malignant hepatic tumors (34 patients with HCC and 22 patients with MLC) underwent RFA treatment. Two weeks following the RFA treatment, contrast-enhance...
full textVirtual Radiofrequency Ablation of Liver Tumors
In the last few years, radiofrequency ablation has become one of the most promising techniques to treat liver tumors. But radiologists have to face the difficulty of planning their treatment while only relying on 2D slices. We present here a realistic radiofrequency ablation simulation tool, coupled with a 3D reconstruction and visualization project. They help radiologists to have a better visu...
full textRadiofrequency Ablation of Miscellaneous Solid Tumors Excluding Liver Tumors - 121616
In radiofrequency ablation (RFA), a probe is inserted into the center of a tumor and the noninsulated electrodes, which are shaped like prongs, are projected into the tumor; a heat is then generated locally by a high-frequency, alternating current that flows from the electrodes. The local heat treats the tissue adjacent to the probe, resulting in a 3 cm to 5.5 cm sphere of dead tissue. The cell...
full textMy Resources
Journal title
volume 28 issue 162
pages 206- 207
publication date 2018-07
By following a journal you will be notified via email when a new issue of this journal is published.
Hosted on Doprax cloud platform doprax.com
copyright © 2015-2023